GlassScriptPhysician profile
Erin Dwyer
NPI 1003260894
$189,014.93
in general payments reported to CMS, 2019-2025
55 companies · $71K in 2025
The $71K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,172 · 2022: $4,025 · 2023: $60K · 2024: $52K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $115K · Food and Beverage: $26K · Consulting Fee: $22K · Travel and Lodging: $20K · Education: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $114,685.95 |
| Food and Beverage | $25,891.99 |
| Consulting Fee | $21,974.30 |
| Travel and Lodging | $20,039.34 |
| Education | $226.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $160,751.11 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $7,186.62 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $4,863.44 | 2021-2025 | Axonics, Lithovue, Rezum Generator |
| Srs Medical Systems, INC. | $3,559.94 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Janssen Biotech, INC. | $2,562.67 | 2022-2025 | Erleada, Akeega, Rybrevant |
| Urogen Pharma, INC. | $1,188.35 | 2021-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $1,159.60 | 2022-2025 | Provenge |
| Procept Biorobotics Corporation | $756.63 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $751.84 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Janssen Scientific Affairs, LLC | $618.33 | 2022-2025 | Erleada, Akeega |
| Abbvie INC. | $514.01 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $490.35 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $473.97 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $458.89 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $389.26 | 2021-2025 | Imfinzi |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $289.84 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $265.03 | 2021-2024 | Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $188.61 | 2021-2023 | Xiaflex |
| Coloplast Corp | $187.25 | 2021-2025 | Titan, Sensura Mio |
| Hollister Incorporated | $179.21 | 2021-2023 | Vapro, Infyna Chic |
| Antares Pharma, INC. | $174.53 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Rochester Medical Corporation | $145.67 | 2022 | |
| Immunitybio, INC. | $134.54 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $133.01 | 2022-2025 | Pylarify |
| Myovant Sciences INC. | $119.77 | 2021-2022 | |
| Photocure INC | $117.89 | 2023 | Cysview |
| 180 Medical, INC. | $117.06 | 2021-2023 | Gentlecath |
| Merck Sharp & Dohme LLC | $106.26 | 2021-2024 | Keytruda |
| Halozyme INC | $88.45 | 2023 | |
| Cycle Pharmaceuticals INC | $87.64 | 2025 | Venxxiva |
| Medtronic, INC. | $82.28 | 2023-2024 | Interstim |
| Palette Life Sciences, INC. | $78.56 | 2022-2023 | |
| Abc Home Medical Supply, INC. | $74.85 | 2022-2023 | |
| Urovant Sciences INC | $72.80 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $72.55 | 2023-2024 | Oxlumo |
| Endo USA, INC. | $72.27 | 2025 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $53.81 | 2025 | Trelstar |
| Laborie Medical Technologies Corp. | $39.61 | 2025 | |
| Telix Pharmaceuticals | $39.24 | 2022-2023 | Illuccix |
| Acerus Pharmaceuticals Corporation | $37.79 | 2022 | |
| Mimedx Group, INC. | $31.05 | 2024 | |
| Olympus America INC. | $30.98 | 2021-2025 | Itind System |
| Ethicon US, LLC | $25.89 | 2024 | Surgicel Nu-Knit, Vistaseal, Evarrest |
| Blue Earth Diagnostics | $25.76 | 2025 | Posluma |
| Convatec INC. | $24.94 | 2023 | |
| Caris Mpi, INC. | $24.83 | 2025 | Mi Cancer Seek |
| Tolmar, INC. | $24.70 | 2023 | |
| Travere Therapeutics, INC. | $24.06 | 2022 | |
| Accord Healthcare, INC. | $20.50 | 2024 | |
| Masimo Corporation | $19.30 | 2022 | |
| Solventum Corporation | $17.55 | 2025 | V.A.C. Veraflo |
| Sagent Pharmaceuticals | $17.09 | 2021 | |
| Valencia Technologies Corporation | $15.66 | 2024 | Ecoin Device Kit |
| Mission Pharmacal Company | $15.55 | 2021 | |
| Smith+Nephew, INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Dwyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.